Millennium Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $90.9M | Buy |
153,372
+89,299
| +139% | +$44.5M | 0.04% | 488 |
|
|
2025
Q4 | $31.2M | Sell |
64,073
-194,504
| -75% | -$90.6M | 0.01% | 1153 |
|
|
2025
Q3 | $108M | Buy |
258,577
+181,513
| +236% | +$61M | 0.05% | 405 |
|
|
2025
Q2 | $22.1M | Buy |
77,064
+73,029
| +1,810% | +$21.8M | 0.01% | 1479 |
|
|
2025
Q1 | $1.24M | Sell |
4,035
-24,024
| -86% | -$8.23M | ﹤0.01% | 4189 |
|
|
2024
Q4 | $9.9M | Buy |
28,059
+19,013
| +210% | +$6.99M | ﹤0.01% | 2192 |
|
|
2024
Q3 | $3.24M | Sell |
9,046
-93,985
| -91% | -$31.7M | ﹤0.01% | 3232 |
|
|
2024
Q2 | $32.8M | Buy |
103,031
+59,354
| +136% | +$15.7M | 0.02% | 1088 |
|
|
2024
Q1 | $10M | Sell |
43,677
-75,532
| -63% | -$17M | ﹤0.01% | 2191 |
|
|
2023
Q4 | $26.2M | Sell |
119,209
-128,219
| -52% | -$29.6M | 0.01% | 1320 |
|
|
2023
Q3 | $55.9M | Buy |
247,428
+116,181
| +89% | +$26.8M | 0.03% | 629 |
|
|
2023
Q2 | $29M | Sell |
131,247
-126,594
| -49% | -$28M | 0.01% | 1097 |
|
|
2023
Q1 | $57.7M | Sell |
257,841
-250,432
| -49% | -$61.7M | 0.03% | 604 |
|
|
2022
Q4 | $141M | Sell |
508,273
-73,437
| -13% | -$18.5M | 0.08% | 246 |
|
|
2022
Q3 | $122M | Buy |
581,710
+100,312
| +21% | +$22.4M | 0.07% | 243 |
|
|
2022
Q2 | $113M | Sell |
481,398
-102,400
| -18% | -$20.8M | 0.07% | 245 |
|
|
2022
Q1 | $105M | Buy |
583,798
+176,658
| +43% | +$33.7M | 0.06% | 318 |
|
|
2021
Q4 | $88M | Buy |
407,140
+40,768
| +11% | +$8M | 0.04% | 411 |
|
|
2021
Q3 | $67.6M | Sell |
366,372
-186,767
| -34% | -$36.8M | 0.04% | 490 |
|
|
2021
Q2 | $99.2M | Buy |
553,139
+152,287
| +38% | +$29M | 0.06% | 301 |
|
|
2021
Q1 | $67.1M | Sell |
400,852
-207,341
| -34% | -$34.6M | 0.05% | 374 |
|
|
2020
Q4 | $92.3M | Buy |
608,193
+128,947
| +27% | +$16.9M | 0.07% | 233 |
|
|
2020
Q3 | $48.4K | Buy |
479,246
+25,875
| +6% | +$2.84M | 0.06% | 333 |
|
|
2020
Q2 | $54.9M | Sell |
453,371
-396,175
| -47% | -$44.6M | 0.08% | 256 |
|
|
2020
Q1 | $80.6M | Sell |
849,546
-263,377
| -24% | -$25M | 0.18% | 86 |
|
|
2019
Q4 | $98M | Sell |
1,112,923
-562,199
| -34% | -$49.5M | 0.12% | 155 |
|
|
2019
Q3 | $134M | Buy |
1,675,122
+13,283
| +0.8% | +$1.07M | 0.21% | 73 |
|
|
2019
Q2 | $130M | Buy |
1,661,839
+1,650,646
| +14,747% | +$154M | 0.2% | 81 |
|
|
2019
Q1 | $1.31M | Sell |
11,193
-25,270
| -69% | -$2.94M | ﹤0.01% | 2695 |
|
|
2018
Q4 | $3.97M | Sell |
36,463
-94,789
| -72% | -$11M | 0.01% | 1741 |
|
|
2018
Q3 | $16.8M | Buy |
131,252
+84,262
| +179% | +$10.4M | 0.02% | 935 |
|
|
2018
Q2 | $5.32M | Sell |
46,990
-120,321
| -72% | -$13.2M | 0.01% | 1777 |
|
|
2018
Q1 | $18.8M | Sell |
167,311
-79,423
| -32% | -$10.1M | 0.03% | 911 |
|
|
2017
Q4 | $36.5M | Sell |
246,734
-69,513
| -22% | -$8.84M | 0.05% | 549 |
|
|
2017
Q3 | $37.1M | Buy |
316,247
+235,608
| +292% | +$30.1M | 0.06% | 456 |
|
|
2017
Q2 | $10.5M | Buy |
+80,639
| New | +$10.1M | 0.02% | 1040 |
|
|
2016
Q4 | – | Sell |
-213,186
| Closed | -$25.2M | – | 3762 |
|
|
2016
Q3 | $25.2M | Buy |
213,186
+66,732
| +46% | +$8.02M | 0.04% | 490 |
|
|
2016
Q2 | $15.5M | Sell |
146,454
-180,877
| -55% | -$20.2M | 0.04% | 646 |
|
|
2016
Q1 | $36.5M | Buy |
327,331
+104,443
| +47% | +$13.2M | 0.09% | 261 |
|
|
2015
Q4 | $34.9M | Buy |
222,888
+6,792
| +3% | +$989K | 0.07% | 359 |
|
|
2015
Q3 | $28.4M | Buy |
216,096
+92,128
| +74% | +$14.8M | 0.05% | 420 |
|
|
2015
Q2 | $21.6M | Sell |
123,968
-102,711
| -45% | -$18.5M | 0.04% | 590 |
|
|
2015
Q1 | $39.1M | Sell |
226,679
-596,795
| -72% | -$91M | 0.07% | 350 |
|
|
2014
Q4 | $107M | Sell |
823,474
-166,258
| -17% | -$21.4M | 0.23% | 64 |
|
|
2014
Q3 | $127M | Buy |
989,732
+806,684
| +441% | +$83.2M | 0.32% | 31 |
|
|
2014
Q2 | $16.2M | Sell |
183,048
-7,315
| -4% | -$703K | 0.04% | 572 |
|
|
2014
Q1 | $17.9M | Buy |
190,363
+2,044
| +1% | +$209K | 0.05% | 499 |
|
|
2013
Q4 | $21.3M | Buy |
188,319
+181,837
| +2,805% | +$16.4M | 0.07% | 327 |
|
|
2013
Q3 | $511K | Sell |
6,482
-69,597
| -91% | -$5.09M | ﹤0.01% | 2535 |
|
|
2013
Q2 | $5.01M | Buy |
+76,079
| New | +$4.9M | 0.02% | 1021 |
|
Other funds holding UTHR
ACA
VPM
VCM
Millennium Management's UTHR Position: Q1 2026 in Review
Millennium Management increased its United Therapeutics (UTHR) stake by 139% in Q1 2026, buying an estimated $44.5M and bringing the position to 153,372 shares worth $90.9M. The position accounts for 0.04% of the portfolio, ranked #488.
Millennium Management first reported a position in UTHR in Q2 2013 and has held it in 50 quarters since. The position peaked at $141M in Q4 2022. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Millennium Management held 153,372 shares of United Therapeutics worth $90.9M as of Q1 2026.
- Millennium Management bought 89,299 United Therapeutics shares in Q1 2026, an estimated $44.5M.
- United Therapeutics made up 0.04% of Millennium Management's portfolio in Q1 2026, its #488 holding.
- Millennium Management first reported a position in United Therapeutics in Q2 2013 and has held it in 50 quarters since.
- Millennium Management's United Therapeutics position peaked at $141M in Q4 2022.
- 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.